GEM

Indian Army Medicines Tender 2025 Lignocaine Omeprazole Montelukast ISI Standards Notified - Department Of Military Affairs

Posted

27 Oct 2025, 11:32 am

Deadline

06 Nov 2025, 12:00 pm

Value

₹50,000

Progress

Issue27 Oct 2025, 11:32 am
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

14880

Category

Lignocaine HCL Solution 2 percentage for IV use 50 ml inj

Bid Type

Two Packet Bid

Key Highlights

  • Medicines list includes Lignocaine HCL 2% IV, Omeprazole, Domperidone, Montelukast, Cetrizine syrup, Norfloxacin, Ondansetron syrup, Bromhexine syrup, Ofloxacin with Ornidazole, Thyroxine 50 mcg.
  • Option clause permits 25% quantity variation during contract or extension; delivery timeline adjusts accordingly.
  • Estimated value around ₹50,000 indicates small-scale medical supply for Army requirements.
  • No explicit EMD amount provided in tender data; verify bid security in official documents.
  • No technical standards specified; bidders should ensure pharmacopoeial quality and compliance with government procurement norms.

Categories 3

Tender Overview

Organization: Indian Army (Department Of Military Affairs). Product/Service: procurement of multiple medicines including Lignocaine HCL 2% IV 50 ml, Omeprazole 20 mg + Domperidone 10 mg capsule, Dicyclomine HCL IP 20 mg + Paracetamol 500 mg tablet, Cetrizine 5 mg/5 ml syrup (60 ml bottle), Montelukast 5 mg tablet, Domperidone 1 mg/ml syrup (30 ml), Norfloxacin 2 mg/5 ml syrup (30 ml), Ondansetron syrup 2 mg/5 ml (30 ml), Bromhexine syrup 4 mg/5 ml (100 ml), Ofloxacin 200 mg + Ornidazole 500 mg tablet, Thyroxine 50 mcg tablet. Estimated value: ₹50,000. Location: not specified in the tender data. The procurement scope covers 11 medicine items with generic packaging. A key differentiator is the option clause allowing up to 25% quantity variation at contract end. This is a government medical supply bid by the Indian Army with minimal technical specs provided.

Technical Specifications & Requirements

  • Medicines listed: Lignocaine HCL 2% IV 50 ml, Omeprazole 20 mg + Domperidone 10 mg capsule, Dicyclomine HCL IP 20 mg + Paracetamol 500 mg tab, Cetrizine 5 mg per 5 ml bottle 60 ml, Montelukast 5 mg tab, Domperidone 1 mg/ml syrup 30 ml, Norfloxacin 2 mg/5 ml syrup 30 ml, Ondansetron syrup 2 mg/5 ml bottle 30 ml, Bromhexine syrup 4 mg/5 ml bottle 100 ml, Ofloxacin 200 mg + Ornidazole 500 mg tab, Thyroxine 50 mcg tab.
  • No explicit technical standards or packaging specs stated beyond naming and unit sizes. Estimated value indicates modest procurement scale. BOQ shows 11 items with N/A quantities, suggesting the need for bidder interpretation of packaging and dosage forms.
  • Critical terms include an option clause enabling up to 25% quantity variation, with delivery timelines tied to the last date of the original or extended delivery period. Bidders should prepare to align with this scope and project delivery planning.
  • No EMD amount is specified in the data; bidders should verify the exact security deposit requirements during bid submission.

Terms, Conditions & Eligibility

  • Option Clause allows up to 25% additional quantity during contract and extension periods, with time calculated by (increased quantity/original quantity) × original delivery days, minimum 30 days.
  • No explicit EMD amount listed; bidders must confirm bid security requirements in the final tender documents.
  • Delivery period alignment depends on last delivery order date and any extended period if option exercised.
  • Bidders must comply with all stated terms and submit medicines meeting the listed product names and dosages. The lack of explicit technical standards implies reliance on standard pharmacopoeial quality and government procurement norms.
  • Ensure readiness for packaging and labeling in line with government supply contracts and potential audits.

Key Specifications

  • Product names and dosage forms listed for 11 items

  • Quantities not specified in BOQ (N/A); prepare to quote per item

  • Estimated value disclosed: ₹50,000

  • Delivery timing governed by option clause with 30-day minimum when extended

  • No explicit ISO/IS standards or pharmacopoeial codes provided

Terms & Conditions

  • Option quantity: up to 25% variation at contract and during currency

  • Delivery schedule ties to last date of original/extended order with formulaic extension

  • EMD amount not specified; confirm bid security requirements in final docs

Important Clauses

Payment Terms

Not specified in data; bidders should verify in official tender docs and align with standard Army procurement practices

Delivery Schedule

Delivery period starts from last date of original delivery order; extended periods allowed with recalculated time

Penalties/Liquidated Damages

Not specified in data; bidder must check final terms for LD or penalties in official notification

Bidder Eligibility

  • Experience in supplying pharmaceutical medicines or hospital consumables

  • GST registration and financial capability to support small-scale procurement

  • Compliance with government procurement norms and drug regulatory requirements

Bill of Quantities (BOQ) 11 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 Lignocaine HCL Solution 2 percentage for IV use 50 ml inj Lignocaine HCL Solution 2 percentage for IV use 50 ml inj 30 vial agniban082 30
2 Omeprazole 20 mg Plus Domperidone 10 mg Capsule Omeprazole 20 mg Plus Domperidone 10 mg Capsule 4,500 no agniban082 30
3 Dicyclomine HCL IP 20 mg Plus Paracetamol 500 mg Tab Dicyclomine HCL IP 20 mg Plus Paracetamol 500 mg Tab 3,000 no agniban082 30
4 Syp Cetrizine 5 mg per 5 ml bott of 60 ml Syp Cetrizine 5 mg per 5 ml bott of 60 ml 300 bott agniban082 30
5 Tab Montelukast 5 mg Tab Montelukast 5 mg 3,000 no agniban082 30
6 Syp Domperidone 1 mg per ml bott of 30 ml Syp Domperidone 1 mg per ml bott of 30 ml 150 bott agniban082 30
7 Syp Norfloxacin 2 mg per 5 ml bott of 30 ml Syp Norfloxacin 2 mg per 5 ml bott of 30 ml 150 bott agniban082 30
8 Ondansetron Syp 2 mg per 5 ml bott of 30 ml Ondansetron Syp 2 mg per 5 ml bott of 30 ml 150 bott agniban082 30
9 Bromhexine Syp 5 ml containing 4 mg of bromhexine HCL bottle of 100 ml Bromhexine Syp 5 ml containing 4 mg of bromhexine HCL bottle of 100 ml 1,200 bott agniban082 30
10 Tab Ofloxacin 200 mg Plus Ornidazole 500 mg Tab Ofloxacin 200 mg Plus Ornidazole 500 mg 1,200 no agniban082 30
11 Tab Thyroxine 50 mcg Tab Thyroxine 50 mcg 1,200 no agniban082 30

AI-Powered Bidder Prediction

Companies most likely to bid

Unlock Bidder Insights

AI predictions on likely bidders

Required Documents

1

GST registration certificate

2

PAN card

3

Experience certificates (similar medical supply projects)

4

Financial statements (last 2-3 years)

5

EMD/Security deposit documentation (as applicable in final tender)

6

Technical bid documents and pharmaceutical compliance certificates

7

OEM authorizations (if branded products are supplied)

Frequently Asked Questions

How to bid for Indian Army medicines tender in 2025?

Bidders should first confirm eligibility for pharmaceutical supply to the Indian Army, secure GST and PAN, gather financials, and obtain any OEM authorizations. Prepare bid documents, ensure the listed medicines match the provided names, and submit with the required EMD/security as per final tender terms.

What documents are required for Army medicine tender submission 2025?

Required documents include GST certificate, PAN card, experience certificates for similar supply, financial statements, EMD documentation, technical compliance certificates, and OEM authorizations if applicable. Ensure packaging and dosage forms correspond to the tendered medicines listed.

What are the delivery terms for Army medicine tenders with option clause?

Delivery terms permit up to 25% quantity variation. The timing is calculated as (increased quantity ÷ original quantity) × original delivery days, with a minimum of 30 days. Original and extended periods depend on the last delivery order date.

What medicines are included in the Indian Army tender 2025?

The tender covers Lignocaine HCL 2% IV 50 ml, Omeprazole 20 mg + Domperidone 10 mg capsule, Dicyclomine HCL IP 20 mg + Paracetamol 500 mg tab, Cetrizine syrup 5 mg/5 ml (60 ml), Montelukast 5 mg tablet, Domperidone syrup 1 mg/ml (30 ml), Norfloxacin syrup 2 mg/5 ml (30 ml), Ondansetron syrup 2 mg/5 ml (30 ml), Bromhexine syrup 4 mg/5 ml (100 ml), Ofloxacin 200 mg + Ornidazole 500 mg tab, and Thyroxine 50 mcg tab.

Is EMD mandatory for this Army medicines tender 2025?

The tender data does not specify an EMD amount; bidders must verify the exact bid security requirements in the final tender documents and ensure compliance before submission.

What is the estimated contract value for Army medicines procurement 2025?

The estimated value is disclosed as ₹50,000 for the 11 medicine items. Bidders should align pricing and packaging with this value and confirm any adjustments if quantities change under the option clause.

Are there any pharmacopoeial or standards requirements for Army medicines?

No explicit standards are listed in the provided data. Bidders should assume standard government pharmaceutical procurement norms and seek final clarification on required certifications, labeling, and quality assurances during bid submission.

When will delivery obligations start after order placement?

Delivery begins after the last date of the original delivery order; if an extended period is triggered by the option clause, the additional time starts from the extended last date, with a minimum 30 days for any extension.